Skip to main content
. 2010 May 24;54(8):3402–3407. doi: 10.1128/AAC.01354-09

FIG. 1.

FIG. 1.

Patient disposition. Four participants did not complete the 14-day period of drug intake. Two patients randomized to PA-824 200 mg and one patient randomized to PA-824 1,200 mg were withdrawn due to adverse events not related to study medication (hemoptysis, n = 1; Wolff-Parkinson-White syndrome, n = 1; urinary tract infection, n = 1). One patient randomized to 1,000 mg PA-824 withdrew consent.